CMS finalizes a rule to include list prices in TV drug ads, Medicare Advantage beneficiaries could save millions thanks to pending telehealth rules, and more news to know.
The value of OTCs to healthcare, the rise of specialty drug spending in Medicare Part D, CMS to test integrated care models for dual eligible beneficiaries, and more industry news to know.
The FDA grants final approval to the first generic naloxone nasal spray, Medicare and Social Security face uncertain financial futures, how Americans feel about ACA protections, and more industry news to know.
In recent months, generic effective rate (GER) clauses in pharmacy contracts have taken center stage as pharmacists become more aware of what exactly this means for them. Though not new, in recent years, GERs have become tighter and more restrictive, leading to the potential for unexpectedly high clawbacks by PBMs at the end of a contract year. Such clauses have shown up in several contracts so far this year, indicating a trend which pharmacists would do well to pay attention to.
As contracts are typically brokered between PSAOs and PBMs, not every pharmacy is or will be affected by GERs. With that in mind, here’s what you need to know about GERs and how they can affect your business.
The measles outbreak is still going strong, U.S. officials are awarding $350 million for research toward ending the opioid epidemic, patient influencers don’t trust pharma websites for health information, and more industry news from the past week.
Last week, executives from the five largest PBMs — CVS Health, Cigna, Prime Therapeutics, Humana, and UnitedHealthcare’s OptumRx — appeared at a Senate Finance Committee hearing to discuss their roles in pharmaceutical supply chain. The high price of prescription drugs has become a rare bipartisan issue.
PBMs say Big Pharma is responsible for high drug prices, Alexa has new HIPAA-compliant skills, D-SNP look-alike plans may soon be at risk, and more industry news from the past week.
Here’s the latest in the world of pharmacy and healthcare:
1. The FDA wants to hear stakeholder experiences with CBD products.
2. The global telemedicine market will hit $130.5 billion by 2025.
3. CMS has introduced new policies to help fight the opioid crisis.
4. CMS has also finalized payment updates to Medicare and Part D plans for 2020.
5. Medicare customers are increasingly looking online for their plans.
Welcome to the first edition of Amplicare’s weekly news roundup. Each week, we’ll share five news stories to keep you up-to-date on what’s happening in the healthcare and pharmaceutical industries. Look for us every Friday afternoon.
The Newest Version of Amplicare Assist.
More win-win opportunities in your workflow, faster speeds, and a visual makeover.